HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

Home April 29, 2022
Home
News | Pharmaceuticals

April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...

Home April 29, 2022
Home
Blog | Cardiovascular Business

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a ...

Home April 29, 2022
Home
News | Ventricular Assist Devices (VAD)

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
News | CT Angiography (CTA)

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Home April 28, 2022
Home
News | Cardiovascular Business

April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid ...

Home April 28, 2022
Home
News | Drug-Eluting Balloons

April 27, 2022 – Medtronic has announced new randomized controlled data demonstrating the sustained and superior ...

Home April 27, 2022
Home
News | Heart Failure
April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...
Home April 27, 2022
Home
News | Interventional Radiology

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

Home April 27, 2022
Home
News | Heart Valve Technology

April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony ...

Home April 27, 2022
Home
News | EP Lab

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home April 27, 2022
Home
News | Stroke
April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose ...
Home April 27, 2022
Home
News | Artificial Heart

April 25, 2022 – There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just ...

Home April 25, 2022
Home
News | Heart Failure

April 25, 2022 — Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer ...

Home April 25, 2022
Home
News | Stroke
April 25, 2022 – Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 ...
Home April 25, 2022
Home
Subscribe Now